Seres Therapeutics Inc (NAS:MCRB)
$ 0.7589 -0.017 (-2.19%) Market Cap: 114.94 Mil Enterprise Value: 221.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Q1 2023 Seres Therapeutics Inc Earnings Call Transcript

May 09, 2023 / 12:30PM GMT
Release Date Price: $5.57 (+0.18%)
Operator

Hello. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Q1 2023 Seres Therapeutics Earnings Conference Call. (Operator Instructions)

Dr. Carlo Tanzi, Investor Relations. You may begin.

Carlo Tanzi
Seres Therapeutics, Inc. - IR Officer

Thank you, and good morning. Our press release for the company's first quarter 2023 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found in the Investors and News section of the company's website. We will also be reviewing new SER-155 Phase Ib study results, and we have posted slides on our corporate website that will accompany our remarks.

I'd like to remind you that we will be making forward-looking statements, including the timing of commercial launch, the availability of VOWST, the commercial success of VOWST, the timing and results of clinical studies, the timing of additional clinical data, final study results, the ability for microbiome therapeutics to modulate for microbiome and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot